These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 18794161)

  • 1. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Nguyen TM; Marions L; Okoev G; Khomassuridze A; Kereszturi A; Mittal S; Nair R; Daver R; Pretnar-Darovec A; Dickson K; Nguyen DH; Nguyen HB; Hoang TD; Peregoudov A;
    Hum Reprod; 2009 Jan; 24(1):106-12. PubMed ID: 18794161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.
    Tang OS; Lau WN; Chan CC; Ho PC
    BJOG; 2004 Sep; 111(9):1001-5. PubMed ID: 15327617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of two intervals and two routes of administration of misoprostol for termination of early pregnancy: a randomised controlled equivalence trial.
    von Hertzen H; Piaggio G; Huong NT; Arustamyan K; Cabezas E; Gomez M; Khomassuridze A; Shah R; Mittal S; Nair R; Erdenetungalag R; Huong TM; Vy ND; Phuong NT; Tuyet HT; Peregoudov A;
    Lancet; 2007 Jun; 369(9577):1938-46. PubMed ID: 17560446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
    Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester pregnancy termination with 600-microg vs. 400-microg vaginal misoprostol and systematic curettage postexpulsion: a randomized trial.
    Carbonell JL; Torres MA; Reyes R; Ortega L; García-Gallego F; Sánchez C
    Contraception; 2008 Jan; 77(1):50-5. PubMed ID: 18082667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial.
    Caliskan E; Doger E; Cakiroglu Y; Corakci A; Yucesoy I
    Eur J Contracept Reprod Health Care; 2009 Feb; 14(1):55-60. PubMed ID: 19241302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12-20 weeks gestation.
    Tang OS; Chan CC; Kan AS; Ho PC
    Hum Reprod; 2005 Nov; 20(11):3062-6. PubMed ID: 16037110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial.
    Tanha FD; Golgachi T; Niroomand N; Ghajarzadeh M; Nasr R
    Arch Gynecol Obstet; 2013 Jan; 287(1):65-9. PubMed ID: 22903515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled comparison of sublingual and vaginal administration of misoprostol for cervical priming before first-trimester surgical abortion.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2004 Jan; 190(1):55-9. PubMed ID: 14749635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy.
    Vimala N; Mittal S; Kumar S; Dadhwal V; Sharma Y
    Contraception; 2004 Aug; 70(2):117-20. PubMed ID: 15288215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion: a randomized trial.
    Carbonell Esteve JL; Marí JM; Valero F; Llorente M; Salvador I; Varela L; Leal P; Candel A; Tudela A; Serrano M; Muñoz E
    Contraception; 2006 Oct; 74(4):328-33. PubMed ID: 16982235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester.
    Tang OS; Mok KH; Ho PC
    Hum Reprod; 2004 May; 19(5):1101-4. PubMed ID: 15070888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion.
    Ganguly RP; Saha SP; Mukhopadhyay S; Bhattacharjee N; Bhattacharyya SK; Patra KK
    J Indian Med Assoc; 2010 May; 108(5):283-4, 286. PubMed ID: 21121402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.